Pretreatment characteristics at time of study entry for 473 patients enrolled in CALGB study 9222
Characteristic . | No. patients (%) . |
---|---|
Age, y | |
17-29 | 94 (20) |
30-39 | 107 (23) |
40-49 | 130 (27) |
50-59 | 142 (30) |
Sex | |
Male | 246 (52) |
Female | 227 (48) |
Race | |
White | 366 (77) |
Black | 54 (11) |
Other | 53 (11) |
Performance status* | |
0 | 135 (29) |
1 | 217 (47) |
2 | 89 (19) |
3 | 20 (4) |
4 | 4 (< 1) |
Characteristic . | No. patients (%) . |
---|---|
Age, y | |
17-29 | 94 (20) |
30-39 | 107 (23) |
40-49 | 130 (27) |
50-59 | 142 (30) |
Sex | |
Male | 246 (52) |
Female | 227 (48) |
Race | |
White | 366 (77) |
Black | 54 (11) |
Other | 53 (11) |
Performance status* | |
0 | 135 (29) |
1 | 217 (47) |
2 | 89 (19) |
3 | 20 (4) |
4 | 4 (< 1) |
n = 465